Dr Rabinder Buttar, CEO and Founder of ClinTec GmbH, Named Deloitte Female Entrepreneur of the Year at UK's Biggest Business Awards
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
26 June 2013: ClinTec International’s founder and CEO, Dr Rabinder Buttar, won the prestigious ‘Female Entrepreneur of the Year’ award at the Scottish Business Awards 2013 held at the Edinburgh International Conference Centre on Friday night. The awards, which are the largest and most prestigious of their kind in the UK, were attended by dignitaries such as President Bill Clinton, Scotland’s First Minister Alex Salmond, and representatives from 1600 businesses, with their combined turnover estimated at around £110bn.
Commenting on winning the accolade and the personnel concerned at ClinTec, her CRO with a presence in over 40 countries worldwide, Dr Buttar said: “Winning this award is great recognition of the work the team and I do in supporting the pharmaceutical industry in developing novel medicines for the treatment of major diseases such as Cancer and Diabetes. As a company, ClinTec has grown substantially since it was founded in 1997, and it is always an honour to win awards such as this. I feel it reflects the work we do and the achievements that we have generated to date from management right through to the work delivered on the ground for our international clients”.
As the founder of ClinTec International, Dr Buttar has seen her clinical research organisation expand into over 40 countries in the space of 17 years, and the company is now ranked as one of the eminent CROs in a variety of key markets across the globe, including the burgeoning Middle East and North Africa (MENA) Region. The company, which is a majority woman owned business, was founded by Dr Buttar in 1997, and can now count ten of the world’s top pharmaceutical companies as clients, as well as having a diverse and multicultural workforce which holds key staff in 43 countries worldwide.
After meeting keynote speaker President Clinton, Dr Buttar was presented with her award by Deloitte’s Senior Partner, Iain Steele. President Clinton’s speech was wide ranging and topical, from speaking about the upcoming Scottish Independence Referendum in 2014, to highlighting the important work his Clinton Foundation Charity conducts in countries such as Malawi, a country in which ClinTec has also helped facilitate important vaccine trials in recent years.
The winning of the award by Dr Buttar marks an important week for ClinTec, which concludes with exhibiting at the 49th Annual DIA Meeting in Boston. The conference, the largest of its kind in the pharmaceutical industry, is being used by the company to formally launch its Masters in International Clinical Research and Technology to the American market, as well as highlighting the company’s new full service offering for the MENA region.
If you would like further information on ClinTec International, Dr Rabinder Buttar, or our new MSc in International Clinical Research and Technology, please contact:
Bobby Bal, Senior Director, Corporate Development,
Glasgow, Scotland, UK.
Phone: +44 (0)141 226 1120
Fax: +44 (0)141 248 8993
Email: bbal@clintec.com
Website: www.clintec.com
About ClinTec International
ClinTec is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec has a presence in over 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.
In addition to ClinTec’s vast expertise in oncology, the organisation has also conducted over 300 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec’s fast, flexible and focused approach to clinical research ensures an added advantage to the drug development process.
For media enquiries, please contact Tristan Jervis on +44 (0) 207 203 6740. E-mail: t.jervis@defacto.com.
Help employers find you! Check out all the jobs and post your resume.
26 June 2013: ClinTec International’s founder and CEO, Dr Rabinder Buttar, won the prestigious ‘Female Entrepreneur of the Year’ award at the Scottish Business Awards 2013 held at the Edinburgh International Conference Centre on Friday night. The awards, which are the largest and most prestigious of their kind in the UK, were attended by dignitaries such as President Bill Clinton, Scotland’s First Minister Alex Salmond, and representatives from 1600 businesses, with their combined turnover estimated at around £110bn.
Commenting on winning the accolade and the personnel concerned at ClinTec, her CRO with a presence in over 40 countries worldwide, Dr Buttar said: “Winning this award is great recognition of the work the team and I do in supporting the pharmaceutical industry in developing novel medicines for the treatment of major diseases such as Cancer and Diabetes. As a company, ClinTec has grown substantially since it was founded in 1997, and it is always an honour to win awards such as this. I feel it reflects the work we do and the achievements that we have generated to date from management right through to the work delivered on the ground for our international clients”.
As the founder of ClinTec International, Dr Buttar has seen her clinical research organisation expand into over 40 countries in the space of 17 years, and the company is now ranked as one of the eminent CROs in a variety of key markets across the globe, including the burgeoning Middle East and North Africa (MENA) Region. The company, which is a majority woman owned business, was founded by Dr Buttar in 1997, and can now count ten of the world’s top pharmaceutical companies as clients, as well as having a diverse and multicultural workforce which holds key staff in 43 countries worldwide.
After meeting keynote speaker President Clinton, Dr Buttar was presented with her award by Deloitte’s Senior Partner, Iain Steele. President Clinton’s speech was wide ranging and topical, from speaking about the upcoming Scottish Independence Referendum in 2014, to highlighting the important work his Clinton Foundation Charity conducts in countries such as Malawi, a country in which ClinTec has also helped facilitate important vaccine trials in recent years.
The winning of the award by Dr Buttar marks an important week for ClinTec, which concludes with exhibiting at the 49th Annual DIA Meeting in Boston. The conference, the largest of its kind in the pharmaceutical industry, is being used by the company to formally launch its Masters in International Clinical Research and Technology to the American market, as well as highlighting the company’s new full service offering for the MENA region.
If you would like further information on ClinTec International, Dr Rabinder Buttar, or our new MSc in International Clinical Research and Technology, please contact:
Bobby Bal, Senior Director, Corporate Development,
Glasgow, Scotland, UK.
Phone: +44 (0)141 226 1120
Fax: +44 (0)141 248 8993
Email: bbal@clintec.com
Website: www.clintec.com
About ClinTec International
ClinTec is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec has a presence in over 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.
In addition to ClinTec’s vast expertise in oncology, the organisation has also conducted over 300 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec’s fast, flexible and focused approach to clinical research ensures an added advantage to the drug development process.
For media enquiries, please contact Tristan Jervis on +44 (0) 207 203 6740. E-mail: t.jervis@defacto.com.
Help employers find you! Check out all the jobs and post your resume.